Altered cerebrovascular-CSF coupling in Alzheimer’s Disease measured by functional near-infrared spectroscopy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Altered cerebrovascular-CSF coupling in Alzheimer’s Disease measured by functional near-infrared spectroscopy ; volume:13 ; number:1 ; day:15 ; month:12 ; year:2023 ; pages:1-8 ; date:12.2023
Scientific reports ; 13, Heft 1 (15.12.2023), 1-8, 12.2023
- Urheber
-
Ferdinando, Hany
Moradi, Sadegh
Korhonen, Vesa
Kiviniemi, Vesa
Myllylä, Teemu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-48965-x
- URN
-
urn:nbn:de:101:1-2024030107442357421031
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ferdinando, Hany
- Moradi, Sadegh
- Korhonen, Vesa
- Kiviniemi, Vesa
- Myllylä, Teemu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cerebrovascular disease in ageing and Alzheimer’s disease
Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer’s disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Cognitive and cerebrovascular improvements following kinin B1receptor blockade in Alzheimer’s disease mice
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
Cerebrovascular disease in ageing and Alzheimer’s disease
Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer’s disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Cognitive and cerebrovascular improvements following kinin B1receptor blockade in Alzheimer’s disease mice
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
Cerebrovascular disease in ageing and Alzheimer’s disease
Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer’s disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Cognitive and cerebrovascular improvements following kinin B1receptor blockade in Alzheimer’s disease mice
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Disease staging of Alzheimer’s disease using a CSF-based biomarker model